SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
Condition(s):Kidney CancerLast Updated:October 20, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Kidney CancerLast Updated:October 20, 2011Completed
Condition(s):Kidney CancerLast Updated:August 12, 2013Unknown status
Condition(s):Kidney CancerLast Updated:June 6, 2013Completed
Condition(s):Kidney CancerLast Updated:January 9, 2014Completed
Condition(s):Kidney CancerLast Updated:June 12, 2013Completed
Condition(s):Kidney CancerLast Updated:August 12, 2013Completed
Condition(s):Kidney CancerLast Updated:November 6, 2013Unknown status
Condition(s):Kidney CancerLast Updated:June 21, 2013Completed
Condition(s):Kidney CancerLast Updated:November 7, 2019Completed
Condition(s):Kidney CancerLast Updated:August 12, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.